[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Supernus Pharm (SUPN)

Supernus Pharm (SUPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
3 Stocks Under $50 with Open Questions

3 Stocks Under $50 with Open Questions

SUPN : 47.77 (-0.91%)
WASH : 32.00 (-0.28%)
IART : 14.88 (-1.46%)
3 Small-Cap Stocks That Concern Us

3 Small-Cap Stocks That Concern Us

SOUN : 8.27 (+1.22%)
SUPN : 47.77 (-0.91%)
OCSL : 11.81 (+0.34%)
3 Growth Stocks We Approach with Caution

3 Growth Stocks We Approach with Caution

SUPN : 47.77 (-0.91%)
BSM : 13.60 (-1.59%)
RGA : 212.26 (-0.83%)
5 Revealing Analyst Questions From Supernus Pharmaceuticals’s Q1 Earnings Call

5 Revealing Analyst Questions From Supernus Pharmaceuticals’s Q1 Earnings Call

SUPN : 47.77 (-0.91%)
Why Supernus Pharmaceuticals (SUPN) Stock Is Up Today

Why Supernus Pharmaceuticals (SUPN) Stock Is Up Today

SUPN : 47.77 (-0.91%)
Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference

ROCKVILLE, Md., May 06, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central...

SUPN : 47.77 (-0.91%)
SUPN Q1 Deep Dive: Growth Products Drive Revenue Upside, Guidance Highlights Execution Challenges

SUPN Q1 Deep Dive: Growth Products Drive Revenue Upside, Guidance Highlights Execution Challenges

SUPN : 47.77 (-0.91%)
1 Healthcare Stock with Competitive Advantages and 2 Facing Challenges

1 Healthcare Stock with Competitive Advantages and 2 Facing Challenges

SUPN : 47.77 (-0.91%)
ELV : 386.64 (-2.04%)
BMY : 58.24 (-2.05%)
Supernus: Q1 Earnings Snapshot

Supernus: Q1 Earnings Snapshot

SUPN : 47.77 (-0.91%)
Supernus Pharmaceuticals’s (NASDAQ:SUPN) Q1 CY2026 Sales Beat Estimates

Supernus Pharmaceuticals’s (NASDAQ:SUPN) Q1 CY2026 Sales Beat Estimates

SUPN : 47.77 (-0.91%)

Barchart Exclusives

Micron Stock Has Soared 200% YTD. Why It May Still Have Room to Run.
Despite the surge, Micron’s valuation still looks attractive relative to its earnings growth potential. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.